ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3038

Enumeration and Preliminary Characterisation of Peri-Entheseal Bone Type 3 Innate Lymphoid Cells

Richard Cuthbert1, Yasser El-Sherbiny1, Evangelos M. Fragkakis1, Robert Dunsmuir2, Helena Marzo-Ortega3, Elena Jones1 and Dennis McGonagle1, 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 2Department of Spinal Surgery, National Health Service, Leeds, United Kingdom, 3NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals and University of Leeds, Leeds, United Kingdom

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Ankylosing spondylitis (AS), innate immunity, pathogenesis and spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Spondylarthropathies Psoriatic Arthritis – Pathogenesis, Etiology I

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose:  In an IL-23 overexpression animal model of spondyloarthropathy (SpA), primary entheseal disease is driven by innate like lymphocytes at peripheral and spinal enthesis with these cells being reported in the enthesis soft tissue-bone interface. We previously described that the normal human entheseal soft tissue (EST) also had a populations of innate lymphoid cells (ILCs) (Cuthbert et al ACR abstract 2015). However, in human SpA the earliest imaging changes may occur in peri-entheseal bone (PEB) with such bone changes, rather than soft tissue changes, being harbingers of eventual joint ankylosis. The purpose of this work was to define PEB ILCs, to examine ILC3 transcriptional profiles and test entheseal responsiveness to IL-23 stimulation in comparison to other ILC3 sources.

Methods:  Human PEB and EST was harvested from normal spinous process in patients undergoing elective spinal orthopaedic procedures. Interspinous EST was dissected from PEB and enzymatically digested. Knee joint synovial fluid cells from active SpA were also collected as a comparator source of ILCs from an inflammatory environment. ILC3s were isolated for RNA analysis by FACS sorting using accepted phenotypic cell surface markers. For cytokine stimulation unsorted PEB digest was incubated for 48 hours in the presence of IL-1β and IL-23. In all cases TaqMan genes expression assays (Applied Biosystems) were used to measure transcripts of interest.

Results:  Bone adjacent to interpinous process attachment sites contained ILCs including ILC3s (6.1×10-3%). RORγt and IL-23R were significantly increased in PEB ILC3 isolates compared to unsorted mononuclear cells (p=0.032 and p=0.033 respectively). Expression of immunomodulatory transcripts IL-10 and TGFβ were comparable in ILC3s isolated from all tissues. STAT3 expression was elevated in ILC3s isolated from PEB (p=0.048) compared to both EST and synovial fluid ILC3s as was TNFα. IL-17A and IL-22 expression was not detected in EST but both were detected in PEB and synovial fluid ILC3s. IL-1β/IL-23 stimulation of PEB resulted in 47-fold induction of IL-17A, 43-fold induction of IL-17F and 51-fold induction of IL-22 transcript.

Conclusion:  This is the first study to define the presence of type 3 ILCs in normal peri-entheseal bone. ILC3s from this location exhibit occasional IL17 gene transcripts which increased substantially following priming. This work adds to the emerging data on ILCs resident populations in the SpA associated target tissues.


Disclosure: R. Cuthbert, None; Y. El-Sherbiny, None; E. M. Fragkakis, None; R. Dunsmuir, None; H. Marzo-Ortega, None; E. Jones, None; D. McGonagle, None.

To cite this abstract in AMA style:

Cuthbert R, El-Sherbiny Y, Fragkakis EM, Dunsmuir R, Marzo-Ortega H, Jones E, McGonagle D. Enumeration and Preliminary Characterisation of Peri-Entheseal Bone Type 3 Innate Lymphoid Cells [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/enumeration-and-preliminary-characterisation-of-peri-entheseal-bone-type-3-innate-lymphoid-cells/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/enumeration-and-preliminary-characterisation-of-peri-entheseal-bone-type-3-innate-lymphoid-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology